Ben Boyarko
YOU?
Author Swipe
View article: Simultaneous Cardiac Surgery for Infective Endocarditis and Liver Transplantation in End-Stage Liver Disease
Simultaneous Cardiac Surgery for Infective Endocarditis and Liver Transplantation in End-Stage Liver Disease Open
Concurrent orthotopic liver transplant surgery and double valve replacement with aorticmitral curtain patch reconstruction for IE can be feasible in very select cases, with successful outcomes hinging on close multidisciplinary collaborati…
View article: Management Strategies of Paravalvular Leak in the Post-Transcatheter Aortic Valve Replacement Patient
Management Strategies of Paravalvular Leak in the Post-Transcatheter Aortic Valve Replacement Patient Open
View article: Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics
Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics Open
Therapeutic research and development for Alzheimer's disease (AD) has been an area of intense research to alleviate memory loss and neurodegeneration. There is growing interest in drug repositioning and repurposing strategies for FDA-appro…
View article: Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin
Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin Open
Tau propagation, pathogenesis, and neurotoxicity are hallmarks of neurodegenerative diseases that result in cognitive impairment. Tau accumulates in Alzheimer’s disease (AD), frontotemporal dementia and parkinsonism linked to chromosome 17…
View article: Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease Open
Therapeutics discovery and development for Alzheimer’s disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes. Recent drug discovery approaches have utilized in silico computation…
View article: Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain
Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain Open
Synaptic dysfunction and loss occur in Alzheimer's disease (AD) brains, which results in cognitive deficits and brain neurodegeneration. Neuropeptides comprise the major group of synaptic neurotransmitters in the nervous system. This study…
View article: Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration Open
The human tau protein is implicated in a wide range of neurodegenerative “tauopathy” diseases, consisting of Alzheimer’s disease (AD) and frontotemporal lobar degeneration which includes progressive supranuclear palsy, corticobasal degener…